North Wales, PA, United States of America

Andrew Evan Denker

USPTO Granted Patents = 7 


 

Average Co-Inventor Count = 5.2

ph-index = 3

Forward Citations = 9(Granted Patents)


Location History:

  • Boston, MA (US) (2012 - 2022)
  • North Wales, PA (US) (2023)
  • Wynnewood, PA (US) (2020 - 2024)
  • Ardmore, PA (US) (2024)

Company Filing History:


Years Active: 2012-2025

Loading Chart...
Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: The Innovations of Andrew Evan Denker

Introduction

Andrew Evan Denker is a notable inventor based in North Wales, PA (US). He has made significant contributions to the field of medicine, particularly in the treatment of various health conditions. With a total of seven patents to his name, Denker's work has the potential to impact many lives.

Latest Patents

Denker's latest patents include innovative methods for treating atypical hemolytic uremic syndrome (aHUS) in pediatric patients. His patent on the dosage and administration of anti-C5 antibodies provides methods for clinical treatment using an anti-C5 antibody or its antigen binding fragment. Additionally, he has developed a combination therapy that includes a PD-1 antagonist and a multi-RTK inhibitor for cancer treatment. This patent describes the use of these combination therapies to enhance the effectiveness of cancer treatments.

Career Highlights

Throughout his career, Denker has worked with prominent companies in the pharmaceutical industry. He has been associated with Merck Sharp & Dohme Corporation and Eisai R&D Management Co., Ltd. His experience in these organizations has contributed to his expertise in developing innovative medical treatments.

Collaborations

Denker has collaborated with notable colleagues, including Yu Kato and Kimiyo Tabata. These partnerships have likely enriched his research and development efforts, leading to groundbreaking innovations in his field.

Conclusion

Andrew Evan Denker's contributions to medical innovation through his patents and collaborations highlight his commitment to improving healthcare. His work continues to pave the way for advancements in treatment options for patients.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…